ConductScience.org, home

Paper2407652

Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.

Lagergard T and 3 others. Infect Immun, 1990. Cited by 65 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Papers, record 2407652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2407652

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid.
PubMed
Journal
Infect Immun
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
2.37
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lagergard TT
2Shiloach JJ
3Robbins JBJ B
4Schneerson RR

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial ToxinsMajor topic
Polysaccharides, BacterialMajor topic
Streptococcus agalactiaeMajor topic
Tetanus ToxoidMajor topic
Animals
Antigens, Bacterial
Immunization
Immunoglobulin G
Immunoglobulin M
Mice
Mice, Inbred BALB C
Phagocytosis

Source PubMed

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,516,876Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.Infect Immun1986https://conductscience.org/library/papers/3516876PubMed
23,540,249Group B streptococcal carriage and disease: a 6-year prospective study.J Pediatr1987https://conductscience.org/library/papers/3540249PubMed
34,572,747Group B streptococcal neonatal and infant infections.J Pediatr1973https://conductscience.org/library/papers/4572747PubMed
46,838,851Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus.Biochemistry1983https://conductscience.org/library/papers/6838851PubMed
52,494,110Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.Infect Immun1989https://conductscience.org/library/papers/2494110PubMed
66,337,145Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus.J Biol Chem1983https://conductscience.org/library/papers/6337145PubMed
76,601,061Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.Infect Immun1983https://conductscience.org/library/papers/6601061PubMed
8396,335Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.J Infect Dis1979https://conductscience.org/library/papers/396335PubMed
94,735,411Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants.J Pediatr1973https://conductscience.org/library/papers/4735411PubMed
106,170,311Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.Biochemistry1981https://conductscience.org/library/papers/6170311PubMed
113,306,379Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.N Engl J Med1987https://conductscience.org/library/papers/3306379PubMed
1284,042Immunodeterminant specificity of human immunity to type III group B streptococcus.J Exp Med1979https://conductscience.org/library/papers/84042PubMed
137,011,033Group B beta-hemolytic streptococci and puerperal infections.Am J Obstet Gynecol1981https://conductscience.org/library/papers/7011033PubMed
147,047,392Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.Infect Immun1982https://conductscience.org/library/papers/7047392PubMed
156,155,346Soluble group- and type-specific antigens from type III group B Streptococcus.Infect Immun1980https://conductscience.org/library/papers/6155346PubMed
163,305,005Neonatal septicemia in Stockholm.Eur J Clin Microbiol1987https://conductscience.org/library/papers/3305005PubMed
1729,937Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera.J Exp Med1978https://conductscience.org/library/papers/29937PubMed
1833,225Isolation of type-specific polysaccharide antigen from group B type Ib streptococci.J Exp Med1979https://conductscience.org/library/papers/33225PubMed
203,900,215An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides.J Immunol Methods1985https://conductscience.org/library/papers/3900215PubMed
217,216,494Antibody to group B Streptococcus type III in human sera measured by a mouse protection test.Infect Immun1981https://conductscience.org/library/papers/7216494PubMed

See all 45 references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
38,932,301Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines.Vaccines (Basel)2024https://conductscience.org/library/papers/38932301PubMed
30,873,933Surface Structures of Group B Streptococcus Important in Human Immunity.Microbiol Spectr2019https://conductscience.org/library/papers/30873933PubMed
25,015,234Maternal vaccination: moving the science forward.Hum Reprod Update2015https://conductscience.org/library/papers/25015234PubMed
14,742,572Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.Infect Immun2004https://conductscience.org/library/papers/14742572PubMed
12,183,534Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.Infect Immun2002https://conductscience.org/library/papers/12183534PubMed
11,425,187Conjugation of yeast mannans with protein employing cyanopyridinium agent (CDAP)--an effective route of antifungal vaccine preparation.Glycoconj J2000https://conductscience.org/library/papers/11425187PubMed
11,119,518Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.Infect Immun2001https://conductscience.org/library/papers/11119518PubMed
11,003,553Determination of the cross-linking effect of adipic acid dihydrazide on glycoconjugate preparation.Glycoconj J1999https://conductscience.org/library/papers/11003553PubMed
10,992,481Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Infect Immun2000https://conductscience.org/library/papers/10992481PubMed
9,746,554Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.Infect Immun1998https://conductscience.org/library/papers/9746554PubMed
9,623,980Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes.Nat Med1998https://conductscience.org/library/papers/9623980PubMed
9,573,106Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy.Infect Immun1998https://conductscience.org/library/papers/9573106PubMed
9,234,768Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.Infect Immun1997https://conductscience.org/library/papers/9234768PubMed
9,125,533Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Infect Immun1997https://conductscience.org/library/papers/9125533PubMed
8,550,227Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons.Infect Immun1996https://conductscience.org/library/papers/8550227PubMed
8,550,068Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.Immunology1995https://conductscience.org/library/papers/8550068PubMed
8,478,094Immunogenicity of Vibrio vulnificus capsular polysaccharides and polysaccharide-protein conjugates.Infect Immun1993https://conductscience.org/library/papers/8478094PubMed
8,406,875Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.Infect Immun1993https://conductscience.org/library/papers/8406875PubMed
8,039,893Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.Infect Immun1994https://conductscience.org/library/papers/8039893PubMed
7,834,605Current status of meningococcal group B vaccine candidates: capsular or noncapsular?Clin Microbiol Rev1994https://conductscience.org/library/papers/7834605PubMed

See all 28 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2407652

GET https://conductscience.org/api/papers/v1/2407652/references?page=2